Half-life of IgE in serum and skin: Consequences for anti-IgE therapy in patients with allergic disease

Journal of Allergy and Clinical Immunology

Volumn 139, Issue 2, 2017, Pages 422-428.e4

  Lawrence, Monica G ^a   Woodfolk, Judith A ^a   Schuyler, Alexander J ^a   Stillman, Leland C ^b   Chapman, Martin D ^b   Platts Mills, Thomas A E ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b INDOOR Biotechnologies Inc   (United States)

Author keywords

half life; IgE; Immunoglobulin; metabolism; omalizumab

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; ALLERGEN; ANTI-IGE ANTIBODIES; ANTIALLERGIC AGENT; ANTIIDIOTYPIC ANTIBODY; PLASMA PROTEIN;

ALLERGIC DISEASE; ARTICLE; DONOR; HALF LIFE TIME; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN DEFICIENCY; PLASMA TRANSFUSION; PRIORITY JOURNAL; SKIN SENSITIVITY; SKIN SENSITIZATION; SKIN TEST; AGAMMAGLOBULINEMIA; HYPERSENSITIVITY; IMMUNOLOGY; IMMUNOTHERAPY; METABOLISM; PROCEDURES; SKIN; TREATMENT OUTCOME; TRENDS;

AGAMMAGLOBULINEMIA; ALLERGENS; ANTI-ALLERGIC AGENTS; ANTIBODIES, ANTI-IDIOTYPIC; BLOOD PROTEINS; HALF-LIFE; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; IMMUNOTHERAPY; SKIN; TREATMENT OUTCOME;

EID: 84997637142     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2016.04.056     Document Type: Article

References (64)

1. 1 Waldmann, T.A., Iio, A., Ogawa, M., McIntyre, O.R., Strober, W., The metabolism of IgE. Studies in normal individuals and in a patient with IgE myeloma. J Immunol 117 (1976), 1139–1144.
2. 2 Ellinger, I., Rothe, A., Grill, M., Fuchs, R., Apical to basolateral transcytosis and apical recycling of immunoglobulin G in trophoblast-derived BeWo cells: effects of low temperature, nocodazole, and cytochalasin D. Exp Cell Res 269 (2001), 322–331.
3. 3 Guha, S., Padh, H., Cathepsins: fundamental effectors of endolysosomal proteolysis. Indian J Biochem Biophys 45 (2008), 75–90.
4. 4 Hamilton, R.G., Adkinson, N.F. Jr., Assessment of human allergic disease. Rich, R.R., (eds.) Clinical immunology, principles and practice, 3rd ed., 2008, Mosby Elsevier, Amsterdam.
5. 5 Casellas, R., Nussenzweig, M.C., Antibodies and their receptors. Austin, K.F., Frank, M.M., Atkison, J.P., Cantor, H., (eds.) Samter's immunologic diseases, 6th ed., 2001, Lippincott William & WIlkins, Philadelphia.
6. 6 Jelinek, D.E., Li, J.T., Immunoglobulin structure and function. Adkinson, N.F., Bochner, B.S., Burks, A.W., Busse, W.W., Holgate, S.T., Lemanske, R.F., et al. (eds.) Middleton's allergy: principle and practice, 8th ed., 2013, Elsevier, Amsterdam.
7. 7 Abbas, A.K., Lichtman, A.H., Pillai, S., Cellular and molecular immunology. 8th ed., 2015, Elsevier Saunders, Philadelphia, viii 535.
8. 8 Platts-Mills, T.A., Snajdr, M.J., Abstract on studies on the half life of IgE, IgA and IgG antibodies to pollen antigens. Allergol Immunopathol 5 (1977), 340–341.
9. 9 Mitchell, E.B., Crow, J., Rowntree, S., Webster, A.D., Platts-Mills, T.A., Cutaneous basophil hypersensitivity to inhalant allergens in atopic dermatitis patients: elicitation of delayed responses containing basophils following local transfer of immune serum but not IgE antibody. J Invest Dermatol 83 (1984), 290–295.
10. 10 Asherson, G., Webster, A., (eds.) Immunoglobulin replacement therapy, 1980, Blackwell Scientific, Oxford.
11. 11 Platts-Mills, T.A., Snajdr, M.J., Ishizaka, K., Frankland, A.W., Measurement of IgE antibody by an antigen-binding assay: correlation with PK activity and IgG and IgA antibodies to allergens. J Immunol 120 (1978), 1201–1210.
12. 12 Kubo, S., Nakayama, T., Matsuoka, K., Yonekawa, H., Karasuyama, H., Long term maintenance of IgE-mediated memory in mast cells in the absence of detectable serum IgE. J Immunol 170 (2003), 775–780.
13. 13 Beck, L.A., Marcotte, G.V., MacGlashan, D., Togias, A., Saini, S., Omalizumab-induced reductions in mast cell FcepsilonRI expression and function. J Allergy Clin Immunol 114 (2004), 527–530.
14. 14 Cass, R.M., Andersen, B.R., The disappearance rate of skin-sensitizing antibody activity after intradermal administration. J Allergy 42 (1968), 29–35.
15. 15 Cheng, L.E., Hartmann, K., Roers, A., Krummel, M.F., Locksley, R.M., Perivascular mast cells dynamically probe cutaneous blood vessels to capture immunoglobulin E. Immunity 38 (2013), 166–175.
16. 16 Saini, S.S., Klion, A.D., Holland, S.M., Hamilton, R.G., Bochner, B.S., Macglashan, D.W. Jr., The relationship between serum IgE and surface levels of FcepsilonR on human leukocytes in various diseases: correlation of expression with FcepsilonRI on basophils but not on monocytes or eosinophils. J Allergy Clin Immunol 106 (2000), 514–520.
17. 17 Bochner, B.S., McKelvey, A.A., Schleimer, R.P., Hildreth, J.E., MacGlashan, D.W. Jr., Flow cytometric methods for the analysis of human basophil surface antigens and viability. J Immunol Methods 125 (1989), 265–271.
18. 18 Malveaux, F.J., Conroy, M.C., Adkinson, N.F. Jr., Lichtenstein, L.M., IgE receptors on human basophils. Relationship to serum IgE concentration. J Clin Invest 62 (1978), 176–181.
19. 19 MacGlashan, D.W. Jr., Basophil activation testing. J Allergy Clin Immunol 132 (2013), 777–787.
20. 20 Ehrlich P. Leipzig University; Beitrage zur Theorie und praxis der histologischen Farbung. Thesis, Leipzig University; 1878.
21. 21 MacGlashan, D. Jr., Histamine: a mediator of inflammation. J Allergy Clin Immunol 112:suppl (2003), S53–S59.
22. 22 Smith, C.H., Kepley, C., Schwartz, L.B., Lee, T.H., Mast cell number and phenotype in chronic idiopathic urticaria. J Allergy Clin Immunol 96 (1995), 360–364.
23. 23 Walpole, S.C., Prieto-Merino, D., Edwards, P., Cleland, J., Stevens, G., Roberts, I., The weight of nations: an estimation of adult human biomass. BMC Public Health, 12, 2012, 439.
24. 24 Krzywicki, H.J., Human body density and fat of an adult male population as measured by water displacement. Laboratory report no. 297, 1966, US Army Medical Research and Nutrition Laboratory, Denver (CO).
25. 25 Schulman, E.S., Kagey-Sobotka, A., MacGlashan, D.W. Jr., Adkinson, N.F. Jr., Peters, S.P., Schleimer, R.P., et al. Heterogeneity of human mast cells. J Immunol 131 (1983), 1936–1941.
26. 26 Coleman, J.W., Godfrey, R.C., The number and affinity of IgE receptors on dispersed human lung mast cells. Immunology 44 (1981), 859–863.
27. 27 Prausnitz, C., Kustner, H., Studien uber die Überempfindlichkeit. Zentralbl Bakteriol, 86, 1921, 160.
28. 28 Iio, A., Waldmann, T.A., Strober, W., Metabolic study of human IgE: evidence for an extravascular catabolic pathway. J Immunol 120 (1978), 1696–1701.
29. 29 Bach, M.K., Bach, S., Brashler, J.R., Ishizaka, T., Ishizaka, K., On the nature of the presumed receptor for IgE on mast cells. V. Enhanced binding of 125I-labeled IgE to cell-free particulate fractions in the presence of protease inhibitors. Int Arch Allergy Appl Immunol 56 (1978), 1–13.
30. 30 Quinn, P.M., Dunne, D.W., Moore, S.C., Pleass, R.J., IgE-tailpiece associates with α-1-antitrypsin (A1AT) to protect IgE from proteolysis without compromising its ability to interact with FcεRI. Sci Rep, 6, 2016, 20509.
31. 31 Rauter, I., Krauth, M.T., Westritschnig, K., Horak, F., Flicker, S., Gieras, A., et al. Mast cell-derived proteases control allergic inflammation through cleavage of IgE. J Allergy Clin Immunol 121 (2008), 197–202.
32. 32 Abdelmotelb, A.M., Rose-Zerilli, M.J., Barton, S.J., Holgate, S.T., Walls, A.F., Holloway, J.W., Alpha-tryptase gene variation is associated with levels of circulating IgE and lung function in asthma. Clin Exp Allergy 44 (2014), 822–830.
33. 33 Iwanaga, T., McEuen, A., Walls, A.F., Clough, J.B., Keith, T.P., Rorke, S., et al. Polymorphism of the mast cell chymase gene (CMA1) promoter region: lack of association with asthma but association with serum total immunoglobulin E levels in adult atopic dermatitis. Clin Exp Allergy 34 (2004), 1037–1042.
34. 34 Mao, X.Q., Shirakawa, T., Enomoto, T., Shimazu, S., Dake, Y., Kitano, H., et al. Association between variants of mast cell chymase gene and serum IgE levels in eczema. Hum Hered 48 (1998), 38–41.
35. 35 Cherayil, B.J., Weiner, S.J., Pillai, S., The Mac-2 antigen is a galactose-specific lectin that binds IgE. J Exp Med 170 (1989), 1959–1972.
36. 36 Frigeri, L.G., Liu, F.T., Surface expression of functional IgE binding protein, an endogenous lectin, on mast cells and macrophages. J Immunol 148 (1992), 861–867.
37. 37 Niki, T., Tsutsui, S., Hirose, S., Aradono, S., Sugimoto, Y., Takeshita, K., et al. Galectin-9 is a high affinity IgE-binding lectin with anti-allergic effect by blocking IgE-antigen complex formation. J Biol Chem 284 (2009), 32344–32352.
38. 38 Arnold, J.N., Radcliffe, C.M., Wormald, M.R., Royle, L., Harvey, D.J., Crispin, M., et al. The glycosylation of human serum IgD and IgE and the accessibility of identified oligomannose structures for interaction with mannan-binding lectin. J Immunol 173 (2004), 6831–6840.
39. 39 Saxon, A., Tsui, F., Martinez-Maza, O., Jacalin, an IgA-binding lectin, inhibits differentiation of human B cells by both a direct effect and by activating T-suppressor cells. Cell Immunol 104 (1987), 134–141.
40. 40 Cheng, L.E., Wang, Z.E., Locksley, R.M., Murine B cells regulate serum IgE levels in a CD23-dependent manner. J Immunol 185 (2010), 5040–5047.
41. 41 Yu, P., Kosco-Vilbois, M., Richards, M., Kohler, G., Lamers, M.C., Negative feedback regulation of IgE synthesis by murine CD23. Nature 369 (1994), 753–756.
42. 42 Greer, A.M., Wu, N., Putnam, A.L., Woodruff, P.G., Wolters, P., Kinet, J.P., et al. Serum IgE clearance is facilitated by human FcepsilonRI internalization. J Clin Invest 124 (2014), 1187–1198.
43. 43 MacGlashan, D. Jr., Xia, H.Z., Schwartz, L.B., Gong, J., IgE-regulated loss, not IgE-regulated synthesis, controls expression of FcepsilonRI in human basophils. J Leukoc Biol 70 (2001), 207–218.
44. 44 Ghetie, V., Hubbard, J.G., Kim, J.K., Tsen, M.F., Lee, Y., Ward, E.S., Abnormally short serum half-lives of IgG in beta 2-microglobulin-deficient mice. Eur J Immunol 26 (1996), 690–696.
45. 45 Israel, E.J., Wilsker, D.F., Hayes, K.C., Schoenfeld, D., Simister, N.E., Increased clearance of IgG in mice that lack beta 2-microglobulin: possible protective role of FcRn. Immunology 89 (1996), 573–578.
46. 46 Junghans, R.P., Anderson, C.L., The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptor. Proc Natl Acad Sci U S A 93 (1996), 5512–5516.
47. 47 Roopenian, D.C., Akilesh, S., FcRn: the neonatal Fc receptor comes of age. Nat Rev Immunol 7 (2007), 715–725.
48. 48 Roopenian, D.C., Christianson, G.J., Sproule, T.J., Brown, A.C., Akilesh, S., Jung, N., et al. The MHC class I-like IgG receptor controls perinatal IgG transport, IgG homeostasis, and fate of IgG-Fc-coupled drugs. J Immunol 170 (2003), 3528–3533.
49. 49 Vaccaro, C., Zhou, J., Ober, R.J., Ward, E.S., Engineering the Fc region of immunoglobulin G to modulate in vivo antibody levels. Nat Biotechnol 23 (2005), 1283–1288.
50. 50 Bundhoo, A., Paveglio, S., Rafti, E., Dhongade, A., Blumberg, R.S., Matson, A.P., Evidence that FcRn mediates the transplacental passage of maternal IgE in the form of IgG anti-IgE/IgE immune complexes. Clin Exp Allergy 45 (2015), 1085–1098.
51. 51 Firan, M., Bawdon, R., Radu, C., Ober, R.J., Eaken, D., Antohe, F., et al. The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of gamma-globulin in humans. Int Immunol 13 (2001), 993–1002.
52. 52 Platts-Mills, T.A., Erwin, E.A., Allison, A.B., Blumenthal, K., Barr, M., Sredl, D., et al. The relevance of maternal immune responses to inhalant allergens to maternal symptoms, passive transfer to the infant, and development of antibodies in the first 2 years of life. J Allergy Clin Immunol 111 (2003), 123–130.
53. 53 Hay, F.C., Hull, M.G., Torrigiani, G., The transfer of human IgG subclasses from mother to foetus. Clin Exp Immunol 9 (1971), 355–358.
54. 54 Corne, J., Djukanovic, R., Thomas, L., Warner, J., Botta, L., Grandordy, B., et al. The effect of intravenous administration of a chimeric anti-IgE antibody on serum IgE levels in atopic subjects: efficacy, safety, and pharmacokinetics. J Clin Invest 99 (1997), 879–887.
55. 55 Hamilton, R.G., Marcotte, G.V., Saini, S.S., Immunological methods for quantifying free and total serum IgE levels in allergy patients receiving omalizumab (Xolair) therapy. J Immunol Methods 303 (2005), 81–91.
56. Platts-Mills, T.A., Snajdr, M.J., Ishizaka, K., Frankland, A.W., Measurement of IgE antibody by an antigen-binding assay: correlation with PK activity and IgG and IgA antibodies to allergens. J Immunol 120 (1978), 1201–1210.
57. Mitchell, E.B., Crow, J., Rowntree, S., Webster, A.D., Platts-Mills, T.A., Cutaneous basophil hypersensitivity to inhalant allergens in atopic dermatitis patients: elicitation of delayed responses containing basophils following local transfer of immune serum but not IgE antibody. J Invest Dermatol 83 (1984), 290–295.
58. Prausnitz, C., Kustner, H., Studien uber die Überempfindlichkeit. Zentralbl Bakteriol, 86, 1921, 160.
59. Smith, C.H., Kepley, C., Schwartz, L.B., Lee, T.H., Mast cell number and phenotype in chronic idiopathic urticaria. J Allergy Clin Immunol 96 (1995), 360–364.
60. Waller, J.M., Maibach, H.I., Age and skin structure and function, a quantitative approach (I): blood flow, pH, thickness, and ultrasound echogenicity. Skin Res Technol 11 (2005), 221–235.
61. Reagan-Shaw, S., Nihal, M., Ahmad, N., Dose translation from animal to human studies revisited. FASEB J 22 (2008), 659–661.
62. Walpole, S.C., Prieto-Merino, D., Edwards, P., Cleland, J., Stevens, G., Roberts, I., The weight of nations: an estimation of adult human biomass. BMC Public Health, 12, 2012, 439.
63. Forbes, R.M., Cooper, A.R., Mitchell, H.H., The composition of the adult human body as determined by chemical analysis. J Biol Chem 203 (1953), 359–366.
64. Krzywicki, H.J., Human body density and fat of an adult male population as measured by water displacement. Laboratory report no. 297, 1966, US Army Medical Research and Nutrition Laboratory, Denver (CO).